Opinion
Video
Author(s):
Panelists discuss how atopic dermatitis impacts different demographic groups through variations in disease presentation, treatment access, and quality of life outcomes.
Education Drives Success in Atopic Dermatitis Treatment
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Rezpegaldesleukin Receives Fast Track Designation for Moderate to Severe AD
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
What’s Next for Topical JAK Inhibitors?
Reviewing Complex Cases: Disruptive AD